pnea upon exertion and also dizziness. The patient denied having any preexisting medical conditions. The initial laboratory results revealed a white blood cell (WBC) count of 22.6 × 10 9 /l with 7% blasts in the peripheral blood. Hemoglobin was 8.3 g/dl and platelet count was 80 × 10 9 /l. The initial bone marrow (BM) was hypercellular marrow with 93.6% blasts. Eosinophilia was not evident in either the peripheral blood or BM. The blasts expressed CD19, CD34, CD13, CD33 and CD11c. The conventional karyotyping showed 47,XX,+21[8]/46,XX,del(?9)(q10),i(9) (q10)[7]/46,XX[5] ( fig. 1 a, b). Fluorescence in situ hybridization (FISH) for PML-RARA , CBFB and KMT2A ( MLL ) were all negative. FISH for RUNX1T1-RUNX1 ( ETO-AML1 ) revealed 3 copies of the AML1 gene in 80% of the blasts. The others were all negative. Under the diagnosis of AML with trisomy 21, the patient received induction chemotherapy with cytarabine and idarubicin. Complete remission was confirmed by a follow-up BM examination on day 26; the blast count was down to 0.3% with a normal karyotype. She subsequently underwent 3 cycles of cytarabine-based consolidation from January to April 2011. A final BM exam was performed in June 2011, showing maintained remission, with a blast count of 0.3% and a normal karyotype. The 8p11 myeloproliferative syndrome (EMS) is a rare yet aggressive disorder molecularly characterized by disruption of the fibroblast growth factor receptor (FGFR1) gene [1] . Clinically, EMS manifests as diverse forms of hematologic malignancies, ranging from myeloproliferative neoplasm to mixed phenotype acute leukemia [2] . The 2008 World Health Organization revision designated EMS to a new category of ‘myeloid and lymphoid neoplasms associated with FGFR1 abnormalities’ [3] . Several partner genes that foster FGFR1 dimerization and activation have been reported, each fusing at 8p11: ZNF198 (13q12), CEP110 (9q33), LRRFIP1 (2q37), FGFR1OP (6q27), TIF1 (7q34), CUX1 (7q22), 11p15, FGFR1OP2 (12p11), CPSF6 (12q15), MYO18A (17q11), 17q25, HERVK (19q13) and BCR (22q11) [4] . Here, we describe an unusual case of a patient with long-standing EMS with t(7; 8), initially diagnosed as acute myeloid leukemia (AML) with trisomy 21, who achieved sustainable molecular and cytogenetic remission with conventional chemotherapy. This is the third reported case of EMS with t(7; 8) translocation worldwide and the first in Korea. In December 2010, a 32-year-old Korean female was admitted to the Seoul National University Bundang Hospital presenting with a 2-week history of worsening dysReceived: November 10, 2015 Accepted after revision: February 7, 2016 Published online: May 18, 2016
[1]
Yonggoo Kim,et al.
Acute myeloid leukemia associated with FGFR1 abnormalities
,
2013,
International Journal of Hematology.
[2]
J. Cowell,et al.
Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities
,
2012,
Leukemia.
[3]
K. R. Jun,et al.
Submicroscopic Deletion of FGFR1 Gene Is Recurrently Detected in Myeloid and Lymphoid Neoplasms Associated with ZMYM2-FGFR1 Rearrangements: A Case Study
,
2012,
Acta Haematologica.
[4]
S. Pileri,et al.
WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.
,
2010,
Pathologica.
[5]
L. Medeiros,et al.
8p11 myeloproliferative syndrome: a review.
,
2010,
Human pathology.
[6]
S. Romana,et al.
LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome
,
2009,
Leukemia.
[7]
J. Choi,et al.
8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
,
2008,
Cancer genetics and cytogenetics.
[8]
F. Lo‐Coco,et al.
8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes
,
2005,
Genes, chromosomes & cancer.
[9]
H. Xiang,et al.
Complete sequence and molecular characterization of pNB101, a rolling-circle replicating plasmid from the haloalkaliphilic archaeon Natronobacterium sp. strain AS7091
,
2004,
Extremophiles.
[10]
A. Reiter,et al.
The 8p11 Myeloproliferative Syndrome: A Distinct Clinical Entity Caused by Constitutive Activation of FGFR1
,
2002,
Acta Haematologica.
[11]
G. Martinelli,et al.
Identification of four new translocations involving FGFR1 in myeloid disorders
,
2001,
Genes, chromosomes & cancer.
[12]
R. Aguiar,et al.
A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review.
,
1995,
Leukemia.
[13]
Tae Sung Parka,et al.
FGFR 1 fusion transcript : morphologic , molecular , and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR 1 abnormality
,
2022
.